Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Findings from burn study demonstrate advantage of Apligraf + autograft versus autograft alone

March 8, 1999

Available for licensing from BTG: immune function modulator with applications in dermatology

March 5, 1999

Luxiq granted marketing clearance by the FDA

March 4, 1999

Genzyme General's Seprafilm approved in Europe for cardiac surgery

Feb. 26, 1999

MS&D launches alopecia treatment in Spain

Feb. 25, 1999

New combination product represents a highly effective approach to acne vulgaris

Feb. 23, 1999

Available for licensing from VUFB: dopamine agonist for dermatology, gastrointestinal indications

Feb. 19, 1999

Early clinical results presented for ABX-IL-8 in psoriasis

Feb. 17, 1999

Fresenius will distribute Genzyme's Sepra products in select European markets

Feb. 17, 1999

Health Canada approves first active wound-healing agent

Feb. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...